Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
Alice MorganSally HartmanisEmmanuel A TsochatzisPhilip Noel NewsomeStephen D RyderRachel ElliottLefteris FlorosRichard HallVictoria HigginsGeorge StanleySandrine CureSharad VasudevanLynne PezzulloPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2021)
The prevention and appropriate management of adult NASH patients could result in reduced economic costs and improvements in wellbeing.